title: Diets for patients with chronic kidney disease, should we reconsider?
abstract: Here we revisit how dietary factors could affect the treatment of patients with complications of chronic kidney disease (CKD), bringing to the attention of the reader the most recent developments in the field. We will briefly discuss five CKD-induced complications that are substantially improved by dietary manipulation: 1) metabolic acidosis and the progression of CKD; 2) improving the diet to take advantage of the benefits of angiotensin converting enzyme inhibitors (ACEi) on slowing the progression of CKD; 3) the diet and mineral bone disorders in CKD; 4) the safety of nutritional methods utilizing dietary protein restriction; and 5) evidence that new strategies can treat the loss of lean body mass that is commonly present in patients with CKD.
authors.affiliation: Department of Medicine, Nephrology Division, Selzman Institute for Kidney Health, Baylor College of Medicine, M/S: BCM 395, One Baylor Plaza, ABBR R703, Houston, TX, 77030, USA. mitch@bcm.edu.
authors.forename: William E
authors.initials: WE
authors.lastname: Mitch
authors.affiliation: IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.|Department of Medicine, Unit of Nephrology and Dialysis, Azienda Socio Sanitaria Territoriale, Papa Giovanni XXIII, Bergamo, Italy.|Department of Biomedical and Clinical Sciences, L. Sacco, University of Milan, Milan, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Remuzzi
mesh_terms: D000138:Acidosis / Q000178:diet therapy* / Q000209:etiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000178:diet therapy* / Q000209:etiology; D018753:Diet, Protein-Restricted / Q000009:adverse effects; D019587:Dietary Supplements; D018450:Disease Progression; D006801:Humans; D007651:Keto Acids / Q000008:administration & dosage*; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000178:diet therapy* / Q000188:drug therapy; D019282:Wasting Syndrome / Q000209:etiology / Q000517:prevention & control
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007651:Keto Acids